Aaron m.Yengo-kahn, john c.Wellons iii, todd c.Hankinson, jason s.Hauptman, eric m.Jackson, hailey jensen, mark d.Krieger, abhaya v.Kulkarni, david.D.Limbrick jr., patrick j.Mcdonald, robert p.Naftel, jonathan a.Pindrik, ian f.Pollack, ron reeder, jay riva-cambrin, curtis j.Rozzelle, mandeep s.Tamber, william e.Whitehead, and john r.W.Kestle.Treatment strategies for hydrocephalus related to dandy-walker syndrome: evaluating procedure selection and success within the hydrocephalus clinical research network.Journal of neurosurgery pediatrics 28 (2021).Doi: 10.3171/2020.11.Peds20806.Objective treating dandy-walker syndrome¿related hydrocephalus (dwsh) involves either a csf shunt-based or endoscopic third ventriculostomy (etv)¿based procedure.However, comparative investigations are lacking.This study aimed to compare shunt-based and etv-based treatment strategies utilizing archival data from the hydrocephalus clinical research network (hcrn) registry.Methods a retrospective review of prospectively collected and maintained data on children with dwsh, available from the hcrn registry (14 sites, 2008¿2018), was performed.The primary outcome was revision-free survival of the initial surgical intervention.The primary exposure was either shunt-based (i.E., cystoperitoneal shunt [cps], ventriculoperitoneal shunt [vps], and/or dual-compartment) or etv-based (i.E., etv alone or with choroid plexus cauterization [cpc]) initial surgical treatment.Primary analysis included multivariable cox proportional hazards models.Results of 8400 hcrn patients, 151 (1.8%) had dwsh.Among these, the 102 patients who underwent shunt placement (79 vpss, 16 cpss, 3 other, and 4 multiple proximal catheter) were younger (6.6 vs 18.8 months, p <(><<)> 0.001) and more frequently had 1 or more comorbidities (37.3% vs 14.3%, p = 0.005) than the 49 etv-treated children (28 etvcpc).Fifty percent of the shunt-based and 51% of the etv-based treatments failed.Notably, 100% (4/4) of the dual compartment shunts failed.Adjusting for age, ba seline ventricular size, and comorbidities, etv-based treatment was not significantly associated with earlier failure compared with shunt-based treatment (hr for failure 1.32, 95% ci 0.77¿2.26; p = 0.321).Complication rates were low: 4.9% and 6.1% (p = 0.715) for shunt- and etv-based procedures, respectively.There was no difference in survival between etv-cpc¿ and etv-based treatment when adjusting for age (hr for failure 0.86, 95% ci 0.29¿2.55, p = 0.783).Reported events.- the overall failure rate was 50%.Notably, 100% of initial complex shunts failed.Of the shunt-based failures the causes are as follows: obstruction (41%), infection (16%), fracture (10%), over/underdrainage (functional) (8%), misplacement (2%), additional proximal catheter required (12%), and other (12%).About 80% of failures resulted in a simple shunt revision (i.E., replacement/revision of the single catheter system).Only 1 shunt was converted to an etv.
|